BriaCell Therapeutics Corp.

C$5.57As of Sun 8 Nov 2026, 12:00 UTC
TSX:BCTHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (52.04%)
Div yield —
ROE (214.79%)
Biotechnology
Beta (5Y) 1.66
PE TTM —
TSR TTM (63.67%)
Mkt cap C$48.64M
ROIC (137.01%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.90
5.91%
(65.74%)
Hold 3|12|5|5|9
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.11
0.12
0.11
0.11
11.69%
12.67%
3.51%
(3.14%)
Revenue$M
3.338
3.297
3.461
3.499
6.28%
7.20%
7.22%
9.97%
Peers (US$34.43M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.501
(0.017)
(0.021)
EBIT/Intx
0.586
0.744
0.690
Own earn%
146.42
(42.02)
(47.62)
Sh yield%
26.35
19.64
19.05
Owners
Insiders/Inst%
14.42
37.36
Short interest%
4.95
SBC / revenue%
2.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
20–23
$1 testx
—
Incr. ROIC%
7